PHARMACEUTICAL DIETARY PREPARATIONS

Brand Owner (click to sort) Address Description
CURAZINK THORNTON & ROSS LIMITED Manchester Road, Linthwaite Huddersfield Yorkshire HD75QH United Kingdom Pharmaceutical and dietary preparations, namely, a zinc supplement; nutritional supplements consisting primarily of zinc;
KAKWA-BIOFARM KAKWA BIOFARM, INC. 6950 ROOKS COURT #306 FREDERICK MD 21703 Pharmaceutical and dietary preparations for treatment and/or control of arthritis, bacterial disease, cancer and tumors, diabetes, endo and ecto-parasites, fungal disease, protozoal infections, viral infections; analgesics, diseases and disorders of the cardiovascular system, diseases and disorders of the gastrointestinal tract, diseases and disorders of the immune system, diseases and disorders of the nervous system, diseases and disorders of the respiratory system;KAKWA BIO FARM;
LACTOFLORA THORNTON & ROSS LIMITED Manchester Road, Linthwaite Huddersfield Yorkshire HD75QH United Kingdom Pharmaceutical and dietary preparations, namely, probiotic supplements; probiotic preparations for medical use to help maintain a natural balance of flora in the digestive system;LACTO FLORA;
MEDFX Boston Research & Development Suite 2 90 Kerry Place Norwood MA 02062 Pharmaceutical and dietary preparations for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders derived from plant extracts for therapeutical purposes;MED FX;
PROBIELLE THORNTON & ROSS LIMITED Manchester Road, Linthwaite Huddersfield Yorkshire HD75QH United Kingdom Pharmaceutical and dietary preparations, namely, probiotic supplements; probiotic preparations for medical use to help maintain a natural balance of flora in the digestive system;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.